Search





Search





Markets
/
Stocks
/
mdt
/

Medtronic PLC

MDT

Add to Watchlist

82.035USD

+0.145+0.18%

Close 07-23 16:00（ET）Quotes delayed by 15 min

105.02BMarket Cap

22.80P/E TTM

Medtronic PLC

82.035

+0.145+0.18%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

+0.18%

5 Days

-1.83%

1 Month

+1.74%

6 Months

-18.68%

Year to Date

-14.60%

1 Year

-10.84%

Key Figures

81.700Open

82.860High

5.54MVolume

22.80P/E TTM

13.73P/E Dynamic

2.830Dividend TTM

0.43%Turnover Ratio

81.890Prev. Close

81.500Low

228.23MTurnover

22.53P/E Static

2.12P/B

3.45%Div Yield TTM

5.11%ROA

106.33052wk High

0.76Volume Ratio

4.66BNet Profit

1.28BShares

3.5981EPS TTM

0.61Beta

9.38%ROE

74.40052wk Low

1.66%Amplitude

61.97%Gross Margin

105.02BMarket Cap

1.79Reward/Risk

1.23%Risk Rate

TradingKey Stock Score of Medtronic PLC

Currency: USD Updated: 2026-07-23

Key Insights

Medtronic PLC's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 33 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 98.22.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Medtronic PLC's Score

Industry at a Glance

Industry Ranking

33 / 200

Overall Ranking

93 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

43°C



Very Low

Very High

Negative

Medtronic PLC Highlights

StrengthsRisks

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 36.36B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 76.98%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 76.98%.

Undervalued

The company’s latest PE is 22.79, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.12B shares, decreasing 3.05% quarter-over-quarter.

Held by Robert Olstein

Star Investor Robert Olstein holds 83.31K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.07.

Analyst Rating

Based on 30 analysts

Buy

Current Rating

98.222

Target Price

+19.27%

Upside Space

Medtronic PLC News

TradingKey The Week on Wall Street: Ceasefire Hopes, AI Boom Lift US Stocks to New Highs; Inflation and Policy Risks Remain

TradingKey - US markets were closed on Monday, May 25, for Memorial Day. Geopolitical optimism surrounding US-Iran diplomatic talks continued to influence markets, with hopes for a ceasefire or deal regarding the Strait of Hormuz. Kevin Warsh, who was sworn in as Federal Reserve Chair on Friday, May

TradingKeyMon, Jun 1

[IN-DEPTH ANALYSIS] Riding the Wave: How Medtronic Capitalizes on the Aging Population

TradingKey - Against the backdrop of the global aging trend and the continuous rise in the incidence of chronic diseases, Medtronic's product portfolio precisely meets the growing demand for diagnosis and treatment. Relying on its global supply chain network and years of accumulated technological...

TradingKeyMay 26, 2025